Former President Joe Biden has completed a course of radiation therapy as he battles prostate cancer, a spokesperson for Biden told CNN. It is unclear what Biden’s next treatment steps might be. The ...

A former journalist has been sentenced to six months in prison, wholly suspended, for inappropriately touching a child at a Townsville pub in 2024. Peter Michael Hardwick, 65, a long-time reporter ...

Doctors at Northwestern Memorial Hospital are the first in Illinois to offer a new treatment for atrial fibrillation, a heart condition that often strikes firefighters. When Jeffrey Taylor first ...

A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive to radiation in specific parts of the rectum than others. The knowledge ...

Chemotherapy fights lung cancer by targeting fast-growing cells. This treatment can cause fatigue, nausea, hair loss, and infection risks. Side effects depend on the drugs and patient. Outcomes vary ...

Former US President Joe Biden has said he is undergoing new treatment for his aggressive form of prostate cancer. A spokesperson for the 46th President said he was having radiation therapy and hormone ...

Former President Joe Biden will undergo radiation therapy to treat his aggressive form of prostate cancer. A spokesperson for the politician announced on Saturday that the 82-year-old will undergo the ...

Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s Hospital in Boston, where a nurse inserts a needle in his arm and a clear ...

Groundbreaking ultrasound technology is revolutionizing cancer treatment, offering non-invasive alternatives to surgery. Techniques like High-Intensity Focused Ultrasound (HIFU) and histotripsy can ...

Clodagh Toomey receives funding from the Health Research Board (Ireland) for research in the area of osteoarthritis. She is affiliated with non-profit initiative GLA:D(r) (Good Life with ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it strengthens T-cell receptors, enhances immune signaling, and improves the ...